- Home
- AKRO vs CNR Comparison
AKRO vs CNR Comparison
Compare AKRO & CNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- CNR
- Stock Information
- Founded
- AKRO 2017
- CNR 1864
- Country
- AKRO United States
- CNR United States
- Employees
- AKRO N/A
- CNR N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- CNR Coal Mining
- Sector
- AKRO Health Care
- CNR Energy
- Exchange
- AKRO Nasdaq
- CNR Nasdaq
- Market Cap
- AKRO 3.9B
- CNR 3.8B
- IPO Year
- AKRO 2019
- CNR N/A
- Fundamental
- Price
- AKRO $45.02
- CNR $74.64
- Analyst Decision
- AKRO Strong Buy
- CNR Strong Buy
- Analyst Count
- AKRO 8
- CNR 4
- Target Price
- AKRO $80.38
- CNR $94.75
- AVG Volume (30 Days)
- AKRO 856.3K
- CNR 689.0K
- Earning Date
- AKRO 08-08-2025
- CNR 08-05-2025
- Dividend Yield
- AKRO N/A
- CNR 0.57%
- EPS Growth
- AKRO N/A
- CNR N/A
- EPS
- AKRO N/A
- CNR 0.51
- Revenue
- AKRO N/A
- CNR $3,275,589,000.00
- Revenue This Year
- AKRO N/A
- CNR $92.77
- Revenue Next Year
- AKRO N/A
- CNR $9.20
- P/E Ratio
- AKRO N/A
- CNR $138.86
- Revenue Growth
- AKRO N/A
- CNR 47.13
- 52 Week Low
- AKRO $21.34
- CNR $58.19
- 52 Week High
- AKRO $58.40
- CNR $134.59
- Technical
- Relative Strength Index (RSI)
- AKRO 38.25
- CNR 54.51
- Support Level
- AKRO $43.08
- CNR $70.36
- Resistance Level
- AKRO $46.18
- CNR $74.41
- Average True Range (ATR)
- AKRO 1.62
- CNR 2.08
- MACD
- AKRO -0.30
- CNR 0.12
- Stochastic Oscillator
- AKRO 29.56
- CNR 94.11
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About CNR Core Natural Resources Inc. Common Stock
Core Natural Resources Inc is a producer and exporter of coal. The company owns and operates longwall mining operations in the nation and export terminals on the Eastern seaboard. The principal activity involves mining, preparation, and marketing of thermal coal, sold to power generators.